Viridien
Short position disclosed on September 22, 2026.
Evolution of the disclosed total
January 7, 2013 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since | Filing |
|---|---|---|---|---|---|
| Capital Fund Management | 1.52% | +0.95 pt | September 15, 2026 | ||
| Marshall Wace LLP | 1.40% | -0.11 pt | September 22, 2026 | ||
| Citadel Advisors LLC | 1.12% | +0.34 pt | September 21, 2026 | ||
| Worldquant, LLC | 1.03% | new | September 22, 2026 | ||
| Walleye Capital LLC | 0.71% | new | August 17, 2026 | AMF | |
| TWO Sigma Investments, LP | 0.70% | new | August 19, 2026 | AMF | |
| Tudor Capital Europe LLP | 0.70% | new | September 21, 2026 | ||
| Acadian Asset Management LLC | 0.64% | new | September 22, 2026 | ||
| Mirabella Financial Services LLP | 0.57% | unchanged | January 30, 2025 | AMF |
In the United States CGPVF (OTC): 7,682 shares sold short on September 15, 2026. FINRA names no fund.
On the other side: the funds that hold Viridien Titelia
Get the moves on Viridien by mail.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
| Date | Fund | % of capital | End of publication | Filing |
|---|---|---|---|---|
| April 28, 2023 | Marshall Wace LLP | 2.33% | August 15, 2023 | |
| April 28, 2023 | Citadel Advisors LLC | 1.10% | July 5, 2023 | |
| April 26, 2023 | Marshall Wace LLP | 2.44% | August 15, 2023 | |
| April 25, 2023 | Marshall Wace LLP | 2.51% | August 15, 2023 | |
| April 25, 2023 | Citadel Advisors LLC | 1.01% | July 5, 2023 | |
| April 24, 2023 | Qube Research & Technologies Limited | 0.93% | March 4, 2024 | |
| April 21, 2023 | Citadel Advisors LLC | 0.90% | July 5, 2023 | |
| April 21, 2023 | Qube Research & Technologies Limited | 0.87% | March 4, 2024 | |
| April 19, 2023 | Citadel Advisors LLC | 0.84% | July 5, 2023 | |
| April 19, 2023 | Qube Research & Technologies Limited | 0.73% | March 4, 2024 | |
| April 19, 2023 | POINT72 Asset Management, L.P. | 0.49% | April 21, 2023 | |
| April 18, 2023 | Citadel Advisors LLC | 0.77% | July 5, 2023 | |
| April 18, 2023 | Qube Research & Technologies Limited | 0.68% | March 4, 2024 | |
| April 17, 2023 | Qube Research & Technologies Limited | 0.74% | March 4, 2024 | |
| April 17, 2023 | Citadel Advisors LLC | 0.68% | July 5, 2023 | |
| April 14, 2023 | Marshall Wace LLP | 2.61% | August 15, 2023 | |
| April 14, 2023 | Citadel Advisors LLC | 0.56% | July 5, 2023 | |
| April 11, 2023 | POINT72 Asset Management, L.P. | 0.59% | April 21, 2023 | |
| April 4, 2023 | Marshall Wace LLP | 2.57% | August 15, 2023 | |
| March 31, 2023 | Marshall Wace LLP | 2.67% | August 15, 2023 | |
| March 31, 2023 | POINT72 Asset Management, L.P. | 0.69% | April 21, 2023 | |
| March 28, 2023 | Marshall Wace LLP | 2.72% | August 15, 2023 | |
| March 27, 2023 | Marshall Wace LLP | 2.66% | August 15, 2023 | |
| March 27, 2023 | Qube Research & Technologies Limited | 0.82% | March 4, 2024 | |
| March 27, 2023 | POINT72 Asset Management, L.P. | 0.77% | April 21, 2023 | |
| March 24, 2023 | Marshall Wace LLP | 2.50% | August 15, 2023 | |
| March 24, 2023 | Qube Research & Technologies Limited | 0.97% | March 4, 2024 | |
| March 22, 2023 | Marshall Wace LLP | 2.20% | August 15, 2023 | |
| March 21, 2023 | Qube Research & Technologies Limited | 1.00% | March 4, 2024 | |
| March 21, 2023 | POINT72 Asset Management, L.P. | 0.89% | April 21, 2023 | |
| March 20, 2023 | POINT72 Asset Management, L.P. | 0.92% | April 21, 2023 | |
| March 17, 2023 | Marshall Wace LLP | 2.13% | August 15, 2023 | |
| March 17, 2023 | POINT72 Asset Management, L.P. | 0.78% | April 21, 2023 | |
| March 16, 2023 | Marshall Wace LLP | 2.01% | August 15, 2023 | |
| March 16, 2023 | Qube Research & Technologies Limited | 0.90% | March 4, 2024 | |
| March 16, 2023 | POINT72 Asset Management, L.P. | 0.65% | April 21, 2023 | |
| March 15, 2023 | POINT72 Asset Management, L.P. | 0.50% | April 21, 2023 | |
| March 14, 2023 | Qube Research & Technologies Limited | 0.87% | March 4, 2024 | |
| March 13, 2023 | Qube Research & Technologies Limited | 0.91% | March 4, 2024 | |
| March 10, 2023 | Qube Research & Technologies Limited | 0.88% | March 4, 2024 | |
| March 9, 2023 | Marshall Wace LLP | 1.81% | August 15, 2023 | |
| March 8, 2023 | Marshall Wace LLP | 1.76% | August 15, 2023 | |
| March 8, 2023 | Qube Research & Technologies Limited | 0.90% | March 4, 2024 | |
| March 7, 2023 | Qube Research & Technologies Limited | 0.87% | March 4, 2024 | |
| March 6, 2023 | Marshall Wace LLP | 1.62% | August 15, 2023 | |
| March 3, 2023 | Marshall Wace LLP | 1.56% | August 15, 2023 | |
| March 3, 2023 | Qube Research & Technologies Limited | 0.94% | March 4, 2024 | |
| March 2, 2023 | Marshall Wace LLP | 1.91% | August 15, 2023 | |
| March 2, 2023 | Qube Research & Technologies Limited | 0.77% | March 4, 2024 | |
| February 24, 2023 | Qube Research & Technologies Limited | 0.60% | March 4, 2024 |
The AMF column opens the filing the fund itself lodged, on the regulator own site.
Download 2491 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in France
- Ubisoft Entertainment 12.35% of the capital sold short
- Valeo 11.29% of the capital sold short
- Renault 9.50% of the capital sold short
- Teleperformance 6.31% of the capital sold short
- FDJ United 6.19% of the capital sold short
- Alstom 4.57% of the capital sold short
- Elis 4.57% of the capital sold short
- Abivax 4.47% of the capital sold short
- Rémy Cointreau 4.46% of the capital sold short
- DBV Technologies 4.21% of the capital sold short
- VusionGroup 3.91% of the capital sold short
- Sopra Steria Group 3.90% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Viridien, source AMF, data as at September 22, 2026, https://www.quivad.com/action/viridien?page=15